Miro Sciences LtdASX: MSX

2026 Annual Report & Appendix 4E

· Issued by Miro Sciences Ltd via ASX

Filed with ASX ·

NeuroScientific Biopharmaceuticals Limited Appendix 4E 1. Company details Name of entity: NeuroScientific Biopharmaceuticals Limited ABN: 13 102 832 995 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2....

View Attachment

6ix hasn’t read this filing yet.

Miro Sciences Ltd on 6ix

Earlier from Miro Sciences

Later from Miro Sciences

All Miro Sciences news releases